Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
02 4Debiopharm Research & Manufacturing SA
03 1PolyPeptide Laboratories Private Limited
04 1Synergy Health AST, Inc
05 3Synergy Health AST, LLC
01 1Triptorelin
02 2Triptorelin Pamoate
03 3Triptorelin pamoate
04 1triptorelin
05 3triptorelin pamoate
01 6Switzerland
02 4U.S.A
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0006
Start Marketing Date : 2006-06-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62788-288
Start Marketing Date : 2001-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (11.25mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 62788-437
Start Marketing Date : 2010-10-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (22.5mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 62788-715
Start Marketing Date : 2000-06-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (3.75mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 62788-956
Start Marketing Date : 2017-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE (22.5mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 59149-006
Start Marketing Date : 2023-02-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (500g/500g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 71161-106
Start Marketing Date : 2017-09-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (22.5mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-103
Start Marketing Date : 2000-06-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (3.75mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-104
Start Marketing Date : 2001-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-105
Start Marketing Date : 2010-03-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (22.5mg/2mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 4 companies offering Triptorelin Pamoate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
